Shares of Chinese autonomous driving company WeRide and AI infrastructure company Nebius popped Friday after Nvidia disclosed stakes in the companies.

Advanced Micro Devices Inc.’s (NASDAQ: AMD) data center revenue came in weaker than expected, raising concerns about ...

Some analysts believe uncertainties facing PepsiCo might be priced in, and the company is in a good position to continue growing.

Investors might want to try to capture stronger returns by finding positive earnings surprises. The Zacks Earnings ESP is more formally known as the Expected Surprise Prediction, and it aims to ...

In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other AI news and ratings you should not miss. DeepSeek is making significant strides in the ...

Apple (AAPL, Financials) posted record revenue and earnings for its fiscal first quarter, reporting $124.3 billion in sales, a 4% increase from a year earlier. Strong demand for services and a ...

Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb and vice versa. The ability to identify stocks that are likely to top ...

In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against Coatue ... These gains are expected to drive earnings growth and contribute to broader ...

Intel (NASDAQ:INTC) just pulled off an earnings beat, posting Q4 revenue of $14.26 billionabove ... The AI chip war with Nvidia (NASDAQ:NVDA) and AMD (NASDAQ:AMD) is heating up, and Intel is ...

In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against Coatue’s other most ... These gains are expected to drive earnings growth and contribute to ...

NVIDIA Corporation (NASDAQ:NVDA) provides graphics, computing and networking solutions. In the report for the fourth quarter of 2024, GAAP earnings ... data center revenue was $18.4 billion ...

Novartis Q4 earnings beat estimates with sales up 16%, driven by strong demand for Entresto, Kesimpta, and Cosentyx. CEO Narasimhan reportedly downplays Entresto's U.S. patent expiration ...